Skip to main content
Table of Contents
Print

Can pregnant or breastfeeding women use medical cannabis safely for PMR? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The use of cannabis in pregnancy or breastfeeding for PMR  requires careful consideration due to potential effects on both maternal and infant health. Evaluating maternal health, foetal safety, and nursing considerations is essential before making any treatment decisions. 

Key Safety Considerations 

Healthcare providers generally advise caution regarding cannabis in pregnancy or breastfeeding for PMR due to limited research and potential risks. 

Maternal Health 

Pregnant or breastfeeding women must consider how cannabis may affect their own health. Monitoring maternal health ensures that any therapy does not compromise well-being during this sensitive period. 

Foetal Safety 

Exposure to cannabis during pregnancy can impact development. Understanding the potential risks is critical for ensuring foetal safety while managing PMR symptoms. 

Breastfeeding Risks 

Cannabinoids can pass into breast milk, which may affect the infant. Awareness of nursing considerations is essential for mothers considering cannabis therapy. 

Alternative Treatments 

Non-cannabis options are often recommended during pregnancy and lactation to minimise risks. These approaches prioritise maternal health and foetal safety while managing PMR symptoms effectively. 

Clinician Guidance 

Consulting with a healthcare provider is crucial. Individual assessment ensures informed decisions about cannabis in pregnancy or breastfeeding for PMR, balancing symptom management and safety. 

Using cannabis in pregnancy or breastfeeding for PMR is generally not recommended due to concerns for maternal health, foetal safety, and nursing considerations. Close collaboration with healthcare professionals is essential to choose the safest approach for symptom relief and overall well-being. 

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories